Danai Laohachewin

ORCID: 0009-0001-3499-7932
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Glycation End Products research
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiovascular Function and Risk Factors
  • S100 Proteins and Annexins
  • Cardiac Imaging and Diagnostics
  • Heart Failure Treatment and Management
  • Cardiac Fibrosis and Remodeling
  • Advanced X-ray and CT Imaging
  • Cardiovascular Health and Disease Prevention
  • Acute Ischemic Stroke Management
  • Diabetes Treatment and Management
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrest and Resuscitation
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Infective Endocarditis Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Diabetes and associated disorders

University of Freiburg
2024

Universitäts-Herzzentrum Freiburg-Bad Krozingen
2024

Heidelberg University
2010-2014

University Hospital Heidelberg
2013-2014

Heidelberg University
2010-2012

Abstract. Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, Laohachewin D, Zankl AR, Kaya Z, Bierhaus A, Giannitsis E, Katus HA, Korosoglou G (University of Heidelberg, Germany). HMGB1 as a predictor infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med 2011; 270: 245–253. Objectives. High-mobility group box 1 (HMGB1) protein is an innate danger signal for the initiation host defence tissue repair. The aim this study was to analyse serum...

10.1111/j.1365-2796.2011.02369.x article EN Journal of Internal Medicine 2011-03-01

Objectives The role of inflammation in atherosclerosis is widely appreciated. High mobility group box 1 (HMGB1), an injury-associated molecular pattern molecule acting as a mediator inflammation, has recently been implicated the development atherosclerosis. In this study, we sought to investigate association plasma HMGB1 with coronary plaque composition patients suspected or known artery disease (CAD). Design HMGB1, high sensitive troponin T (hsTnT) and C-reactive protein (hsCRP) were...

10.1371/journal.pone.0052081 article EN cc-by PLoS ONE 2012-12-17

Background: The goal of our study is to evaluate a method quantify aortic valve calcification (AVC) in contrast-enhanced computed tomography for patients with suspected severe stenosis pre-interventionally. Methods: A total sixty-five underwent both native and (CECT) scan the (45 training cohort 20 validation cohort) using standardized protocol. Aortic was semi-automatically quantified via Agatston score scans used as reference. For tomography, calcium threshold Hounsfield units aorta plus...

10.3390/jcm13082386 article EN Journal of Clinical Medicine 2024-04-19

Tumour embolisms are rare and in most cases sudden causes of death. Diagnosing this condition is still very challenging the daily clinical routine. In report we present a case lethal pulmonary tumour embolism 71-year-old male patient, who was admitted for elective invasive coronary angiography due to suspected artery disease. The patient had Ormond's disease no previous history burden. Possible diagnostic treatment options discussed herein an overview current literature also presented.

10.1155/2014/396832 article EN cc-by Case Reports in Medicine 2014-01-01

Aims: Increasing evidence has established causative links between chronic inflammation and insulin resistance type 2 diabetes mellitus. The aim of this study is to evaluate the role High-mobility group box 1 (HMGB1), a potent innate "danger signal", in induction propagation inflammatory response an animal model diet induced obesity/type (DIO) alone combination with pressure overload hypertrophy after transverse aortic constriction (TAC).

10.1055/s-0033-1341699 article EN Diabetologie und Stoffwechsel 2013-04-19
Coming Soon ...